Report Company Directory
- NRG Yield, Inc. Reports First Quarter 2018 Financial Results by BusinessWire
- NRG Yield to Report First Quarter 2018 Financial Results on May 3, 2018 by BusinessWire
- NRG Yield Operating LLC, a Subsidiary of NRG Yield, Inc., Announces Termination of Consent Solicitation for its 5.375% Senior Notes due 2024 and 5.000% Senior Notes due 2026 by BusinessWire
- NRG Yield Operating LLC, a Subsidiary of NRG Yield, Inc., Announces Extension of Consent Solicitation for its 5.375% Senior Notes due 2024 and 5.000% Senior Notes due 2026 by BusinessWire
- NRG Yield Operating LLC, a Subsidiary of NRG Yield, Inc., Announces Consent Solicitation for Its 5.375% Senior Notes Due 2024 and 5.000% Senior Notes Due 2026 by BusinessWire
- NRG Yield, Inc. Reports Full Year 2017 Financial Results And Increases Quarterly Dividend by BusinessWire
- NRG Yield, Inc. Increases Quarterly Dividend by 3.47% to $0.298 per Share by BusinessWire
- Moody's affirms NRG Yield's Ba2 ratings; stable outlook by Moody's Investors Service
- NRG Yield Announces New Sponsorship with Global Infrastructure Partners and Agreements on Next Drop Down Transactions by BusinessWire
- NRG Yield to Report Full Year and Fourth Quarter 2017 Financial Results on March 1, 2018 by BusinessWire
- NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion by GlobeNewsWire
- NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Transcranial Magnetic Stimulation by GlobeNewsWire
- NRx Pharmaceuticals Announces US Food and Drug Administration (FDA) Receipt of ANDA for KETAFREE™, a Preservative-Free IV Ketamine by GlobeNewsWire
- NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call by GlobeNewsWire
- NRx Pharmaceuticals (NASDAQ:NRXP) and HOPE Therapeutics to Present at NobleCon21 - Noble Capital Markets’ Twenty First Annual Emerging Growth Equity Conference by GlobeNewsWire
- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Third Quarter 2025 Financial Results and Provides Corporate Update by GlobeNewsWire
- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2025 Financial Results on November 17, 2025 by GlobeNewsWire
- HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health by GlobeNewsWire
- HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director by GlobeNewsWire
- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference by GlobeNewsWire